4//SEC Filing
ATLAS VENTURE ASSOCIATES X, L.P. 4
Accession 0001209191-21-057719
CIK 0001733294other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 8:59 PM ET
Size
24.2 KB
Accession
0001209191-21-057719
Insider Transaction Report
Form 4
ATLAS VENTURE ASSOCIATES X, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-09-22$25.89/sh−30,560$791,229→ 185,126 total - Sale
Common Stock
2021-09-23$26.55/sh−1$27→ 109,801 total - Sale
Common Stock
2021-09-24$25.84/sh−28,862$745,765→ 80,939 total - Sale
Common Stock
2021-09-22$25.89/sh−57$1,476→ 951 total(indirect: See footnote) - Sale
Common Stock
2021-09-23$26.13/sh−75,324$1,968,442→ 109,802 total - Sale
Common Stock
2021-09-23$26.13/sh−140$3,659→ 811 total(indirect: See footnote) - Sale
Common Stock
2021-09-24$25.84/sh−54$1,395→ 757 total(indirect: See footnote)
Holdings
- 7,111,939(indirect: See footnote)
Common Stock
- 1,166,937(indirect: See footnote)
Common Stock
Footnotes (8)
- [F1]Shares were sold pursuant to a Rule 10b5-1 trading plan dated April 20, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.54 to $26.21 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(4) and (5).
- [F3]The shares are held directly by Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. AVA X LLC disclaims Section 16 beneficial ownership of the securities held by AVA X LP except to the extent of its pecuniary interest therein, if any.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.53 to $26.518 inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.40 to $26.21 inclusive.
- [F6]The shares are held directly by Atlas Venture Associates Opportunity I, LP ("AVAO LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. AVAO LLC disclaims Section 16 beneficial ownership of the securities held by AVAO LP except to the extent of its pecuniary interest therein, if any.
- [F7]The shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is AVA X LP. AVA X LLC is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of its pecuniary interest therein, if any.
- [F8]The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is AVAO I LP. AVAO I LLC is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001742766
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 8:59 PM ET
- Size
- 24.2 KB